Niagen Bioscience Inc (NAGE) Earnings History
Annual and quarterly earnings data from 2007 to 2025
Loading earnings history...
NAGE EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NAGE Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 64.3% | 11.0% | 13.4% |
| 2024 | 61.8% | 7.8% | 8.6% |
| 2023 | 60.8% | -6.7% | -5.9% |
| 2022 | 59.4% | -25.9% | -23.0% |
| 2021 | 61.5% | -40.1% | -40.2% |
Download Data
Export NAGE earnings history in CSV or JSON format
Free sign-in required to download data
Niagen Bioscience Inc (NAGE) Earnings Overview
As of May 8, 2026, Niagen Bioscience Inc (NAGE) reported trailing twelve-month net income of $17M, reflecting +81.8% year-over-year growth. The company earned $0.21 per diluted share over the past four quarters, with a net profit margin of 13.4%.
Looking at the long-term picture, NAGE's historical earnings data spans multiple years. The company achieved its highest annual net income of $17M in fiscal 2025, representing a new all-time high.
Niagen Bioscience Inc maintains positive profitability with a gross margin of 64.3%, operating margin of 11.0%, and net margin of 13.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including NRXP (-$38M net income, -2336.5% margin), HALO ($317M net income, 22.7% margin), NBIX ($669M net income, 16.7% margin), NAGE has outperformed on profitability metrics. Compare NAGE vs NRXP →
NAGE Earnings vs Peers
Earnings metrics vs comparable public companies
NAGE Historical Earnings Data (2007–2025)
19 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $17M | +103.3% | $14M | $0.20 | 13.4% | 11.0% |
| 2024 | $9M | +273.1% | $8M | $0.11 | 8.6% | 7.8% |
| 2023 | -$5M | +70.1% | -$6M | $-0.07 | -5.9% | -6.7% |
| 2022 | -$17M | +39.0% | -$19M | $-0.24 | -23.0% | -25.9% |
| 2021 | -$27M | -36.2% | -$27M | $-0.40 | -40.2% | -40.1% |
| 2020 | -$20M | +38.0% | -$20M | $-0.33 | -33.6% | -33.5% |
| 2019 | -$32M | +3.5% | -$31M | $-0.56 | -69.4% | -67.6% |
| 2018 | -$33M | -192.8% | -$33M | $-0.61 | -105.6% | -105.1% |
| 2017 | -$11M | -288.6% | -$16M | $-0.26 | -53.7% | -77.2% |
| 2016 | -$3M | -5.7% | -$3M | $-0.08 | -13.5% | -13.4% |
See NAGE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NAGE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NAGE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNAGE — Frequently Asked Questions
Quick answers to the most common questions about buying NAGE stock.
Is NAGE growing earnings?
NAGE EPS is $0.21, with earnings growth accelerating to +81.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $17M.
What are NAGE's profit margins?
Niagen Bioscience Inc net margin is +13.4%, with operating margin at +11.0%. Margins sit within typical range for the sector.
How consistent are NAGE's earnings?
NAGE earnings data spans 2007-2025. The accelerating earnings trend is +81.8% YoY. Historical data enables comparison across business cycles.